title: Tumour necrosis factor alpha blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis: a 2-year pilot study.
authors.forename: Lai-Shan
authors.initials: LS
authors.lastname: Tam
authors.forename: Edmund K
authors.initials: EK
authors.lastname: Li
authors.forename: Qing
authors.initials: Q
authors.lastname: Shang
authors.forename: Brian
authors.initials: B
authors.lastname: Tomlinson
authors.forename: Martin
authors.initials: M
authors.lastname: Li
authors.forename: Ying-Ying
authors.initials: YY
authors.lastname: Leung
authors.forename: Woon Pang
authors.initials: WP
authors.lastname: Kuan
authors.forename: Lai-Wa
authors.initials: LW
authors.lastname: Kwok
authors.forename: Tena K
authors.initials: TK
authors.lastname: Li
authors.forename: Yaner
authors.initials: Y
authors.lastname: Zhu
authors.forename: Emily W
authors.initials: EW
authors.lastname: Kun
authors.forename: Gabriel
authors.initials: G
authors.lastname: Yip
authors.forename: Cheuk-Man
authors.initials: CM
authors.lastname: Yu
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D002339:Carotid Arteries / Q000473:pathology*; D005500:Follow-Up Studies; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha